Search results
Results From The WOW.Com Content Network
The fecal immunochemical test (FIT) is a diagnostic technique that examines stool samples for traces of non-visible blood, which could potentially indicate conditions including bowel cancer. [1] Symptoms which could be caused by bowel cancer and suggest a FIT include a change in bowel habit, anaemia , unexplained weight loss, and abdominal pain .
Routine screening of women with a glucose challenge test may find more women with gestational diabetes than only screening women with risk factors. [39] Hemoglobin A 1c (HbA1c) is not recommended for diagnosing gestational diabetes, as it is a less reliable marker of glycemia during pregnancy than oral glucose tolerance testing (OGTT). [40] [41]
Gestational diabetes: GERD Gastroesophageal reflux disease: GI Gastrointestinal: GIB Gastrointestinal bleeding: GN Glossopharyngeal neuralgia: GORD Gastro-oesophageal reflux disease: GSS disease Gerstmann–Sträussler–Scheinker disease: GT/LD Gifted and learning disabled: GVHD Graft-versus-host disease: GWD Guinea worm disease
Fecal occult blood testing (FOBT), as its name implies, aims to detect subtle blood loss in the gastrointestinal tract, anywhere from the mouth to the colon.Positive tests ("positive stool") may result from either upper gastrointestinal bleeding or lower gastrointestinal bleeding and warrant further investigation for peptic ulcers or a malignancy (such as colorectal cancer or gastric cancer).
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
This is a shortened version of the eleventh chapter of the ICD-9: Complications of Pregnancy, Childbirth, and the Puerperium. It covers ICD codes 630 to 679. The full chapter can be found on pages 355 to 378 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.
The following disorders are additional conditions that may be detected by screening. Many are listed as "secondary targets" by the 2005 ACMG report. [1] Some states are now screening for more than 50 congenital conditions. Many of these are rare and unfamiliar to pediatricians and other primary health care professionals. [1] Blood cell disorders
(This interval does not apply to people at high risk of colorectal cancer or those who experience symptoms of the disease.) [28] [29] The large randomized pragmatic clinical trial NordICC was the first published trial on the use of colonoscopy as a screening test to prevent colorectal cancer, related death, and death from any cause. It included ...